Long-acting basal insulin analogue

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameLong-acting basal insulin analogue
Drug Alias NameNN-1436LAI-287NN-1956Long-acting basal insulin analogueLong-acting-insulin-287 +[10] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[20] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/S
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A